Literature DB >> 4206344

Immunological studies on the envelope component of Venezuelan equine encephalomyelitis virus.

C E Pedersen, D R Slocum, G A Eddy.   

Abstract

Treatment of purified Venezuelan equine encephalomyelitis virus with the nonionic detergent Triton X-100 permitted spearation of the envelope from the core component. The isolated envelope was a noninfectious immunogen which reacted in hemagglutination, hemagglutination inhibition, complement fixation, and neutralization serological reactions.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4206344      PMCID： PMC422948          DOI： 10.1128/iai.8.6.901-906.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  37 in total

1.  Basic structure of group A arbovirus strains Middelburg, Sindbis, and Semliki Forest examined by negative staining.

Authors:  R W Simpson; R E Hauser
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

2.  Proteins synthesized in chick cells following infection with Semliki Forest virus.

Authors:  A J Hay; J J Skehel; D C Burke
Journal:  J Gen Virol       Date:  1968-09       Impact factor: 3.891

3.  Investigations on the formation and interconversion of Sindbis virus hemagglutinins.

Authors:  P Faulkner; P Dobos
Journal:  Can J Microbiol       Date:  1968-01       Impact factor: 2.419

4.  Sindbis virus infection of chick and hamster cells: synthesis of virus-specific proteins.

Authors:  J H Strauss; B W Burge; J E Darnell
Journal:  Virology       Date:  1969-03       Impact factor: 3.616

5.  Maturation defects in temperature-sensitive mutants of Sindbis virus.

Authors:  F H Yin; R Z Lockart
Journal:  J Virol       Date:  1968-07       Impact factor: 5.103

6.  Identification of the membrane protein and "core" protein of Sindbis virus.

Authors:  J H Strauss; B W Burge; E R Pfefferkorn; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1968-02       Impact factor: 11.205

7.  Changes in morphology, infectivity and haemagglutinating activity of Semliki Forest virus produced by the treatment with caseinase C from Streptomyces albus G.

Authors:  P M Osterrieth; C M Calberg-Bacq
Journal:  J Gen Microbiol       Date:  1966-04

8.  Replication of Semliki Forest virus: an electron microscopic study.

Authors:  N H Acheson; I Tamm
Journal:  Virology       Date:  1967-05       Impact factor: 3.616

9.  Replication of Western equine encephalomyelitis virus. II. Cytoplasmic structure involved in the synthesis and development of the virions.

Authors:  T Sreevalsan; P T Allen
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

10.  Structural and nonstructural proteins of an arbovirus.

Authors:  R M Friedman
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103
View more
  6 in total

1.  Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses.

Authors:  C E Pedersen
Journal:  J Clin Microbiol       Date:  1976-02       Impact factor: 5.948

2.  Separation, isolation, and immunological studies of the structural proteins of Venezuelan equine encephalomyelitis virus.

Authors:  C E Pedersen; G A Eddy
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

3.  Cholesterol requirement of mycoplasmas as determined by microtiter test using polyene antibiotics.

Authors:  M W Grabowski; S Rottem; M F Barile
Journal:  J Clin Microbiol       Date:  1976-02       Impact factor: 5.948

4.  Effects of antigen-antibody complexes on the primary immune response in Rhesus monkeys.

Authors:  W E Houston; C E Pedersen; F E Cole; R O Spertzel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

5.  Morphological, chemical, and biological characterization of Japanese encephalitis virus virion and its hemagglutinin.

Authors:  T Kitano; K Suzuki; T Yamaguchi
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

6.  Virus-induced alterations in insulin release in hamster islets of Langerhans.

Authors:  E J Rayfield; Y Seto; S Walsh; R C McEvoy
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.